Oropharyngeal sanitization with electrolyzed superoxidation solution with neutral pH to prevent COVID-19

Phase 2

Completed

• Conditions: COVID-19; SARS-CoV2; Coronaviridae Infections; Nidovirales Infections; Betacoronavirus; Disease Prevention; SARS Virus; Coronavirus Infections

• Registration Number: RPCEC00000357
• Lead Sponsor: Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-03-16
• Study Completion: 2021-04-01
• Results First Posted: 2021-05-03
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 170

Inclusion Criteria

1. Volunteer health professionals, over 18 years of age and belonging to the first line of care for COVID-19 patients.
2. Health professionals belonging to the Dr. Enrique Cabrera Cosio Hospital.
3. Negative diagnosis for SARS-CoV-2 by PCR.
4. Sign informed consent in writing of the volunteer.

Exclusion Criteria

1. Over 70 years of age.
2. Positive diagnosis for SARS-CoV-2 by PCR.
3. Presence of symptoms compatible with COVID-19.
4. Other pathologies at the discretion of the researcher.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Absence of symptoms associated with COVID-19 in health professionals on the first line of care of COVID-19 patients (Yes, No). Measurement time: At baseline and, daily over the course of 4 weeks.

Secondary Outcome Measures

Name	Time	Method
Adverse effects (oropharyngeal irritation, intolerance to application). Measurement time: At baseline and, throughout the course of the study (four weeks)